| scholarly article | Q13442814 |
| P2093 | author name string | Kirsten L Johansen | |
| George A Kaysen | |||
| Cynthia Delgado | |||
| Anne L Schafer | |||
| Janet M Chiang | |||
| P2860 | cites work | Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members | Q24683254 |
| The moderator–mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations | Q25938996 | ||
| Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus | Q28315009 | ||
| Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis | Q29619610 | ||
| Associations between serum leptin level and bone turnover in kidney transplant recipients | Q30429441 | ||
| Novel bone endocrine networks integrating mineral and energy metabolism | Q33572134 | ||
| Relevant use of Klotho in FGF19 subfamily signaling system in vivo | Q33667883 | ||
| Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis | Q33932297 | ||
| FGF23 induces left ventricular hypertrophy | Q34028891 | ||
| Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjects | Q34034905 | ||
| Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity | Q34123954 | ||
| Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders. | Q34418714 | ||
| Associations of fibroblast growth factor-23 with markers of inflammation, insulin resistance and obesity in adults | Q35220170 | ||
| Racial differences in markers of mineral metabolism in advanced chronic kidney disease | Q35860700 | ||
| Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity | Q35921334 | ||
| Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy | Q36348861 | ||
| Low body mass index and dyslipidemia in dialysis patients linked to elevated plasma fibroblast growth factor 23. | Q37029683 | ||
| Abdominal subcutaneous adipose tissue: a protective fat depot? | Q37189254 | ||
| Inflammation regulates fibroblast growth factor 23 production | Q37243107 | ||
| A systems biology preview of the relationships between mineral and metabolic complications in chronic kidney disease. | Q37365294 | ||
| Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease | Q37781747 | ||
| Leptin stimulates fibroblast growth factor 23 expression in bone and suppresses renal 1alpha,25-dihydroxyvitamin D3 synthesis in leptin-deficient mice | Q38346068 | ||
| Fibroblast Growth Factor 23, Mineral Metabolism, and Adiposity in Normal Kidney Function | Q40282640 | ||
| Effects of body size and body composition on survival in hemodialysis patients | Q44560808 | ||
| The causal mediation formula--a guide to the assessment of pathways and mechanisms | Q46591703 | ||
| Adiponectin alters renal calcium and phosphate excretion through regulation of klotho expression | Q50005951 | ||
| 'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. | Q51174746 | ||
| Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver. | Q51421300 | ||
| Circulating Fibroblast Growth Factor-23 Is Associated With Fat Mass and Dyslipidemia in Two Independent Cohorts of Elderly Individuals | Q56109646 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 278-282 | |
| P577 | publication date | 2018-03-29 | |
| P1433 | published in | Journal of Renal Nutrition | Q6295855 |
| P1476 | title | Fibroblast Growth Factor 23 is Associated With Adiposity in Patients Receiving Hemodialysis: Possible Cross Talk Between Bone and Adipose Tissue | |
| P478 | volume | 28 |
| Q58726402 | Association between resistin and fibroblast growth factor 23 in patients with type 2 diabetes mellitus | cites work | P2860 |
Search more.